Clinical trial · Interventional
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Combination of the EMDR Integrative Group Protocol and Individual EMDR Treatment in Patients With Advanced Thyroid Cancer: A Pilot Study
NCT07447089CI-TRIAL-00104530recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using a process-outcome study design, with repeated measures.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasm | Neoplasm | ONTOLOGY_EXACT | 0.90 |
| Post-traumatic Stress Disorder (PTSD) | — | UNRESOLVED | — |
| Psychological Distress | — | UNRESOLVED | — |
| Thyroid Neoplasms | Thyroid Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EMDR-IGTP-OTS | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- EMDR Treatment Group
- description
- Participants receive an integrated EMDR intervention consisting of the EMDR Integrative Group Protocol (IGTP-OTS) followed by additional individual EMDR sessions when needed. The treatment focuses on processing traumatic memories related to personal experiences cancer-related.
- interventionNames
- Behavioral: EMDR-IGTP-OTS
Primary outcomes (1)
- measure
- Impact of Event Scale-Revised (IES-R)
- timeFrame
- Baseline (T1) and Post-intervention (T2, approximately 1 month), Follow-up (T3, approximately 3 month)
- description
- Impact of Event Scale-Revised range: The scale is composed by 22 items, each scored 0-4 (Min Score: 0; Max Score: 88). A higher score indicates a higher intensity of post-traumatic stress symptoms
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * cancer diagnosis * PTSD (IES-R \> 32) Exclusion Criteria: * receiving specialized trauma therapy * receiving current psychiatric pharmacological treatment, unless the dosage has been stable for at least 2 months prior to enrollment
References
Publications (3)
- BACKGROUNDQuaranta-Leech, A., Zaporozhets, O., Jarero, I., & Holland, D. (2025). Randomized Controlled Trial on the Provision of the EMDR-IGTP-OTS-R for Reduction of Posttraumatic Stress Disorder Symptomology with Mental Health Professionals in Ukraine during the War. Journal of EMDR Practice and Research, 19, 0007.
- BACKGROUNDJarero, I., Artigas, L., Uribe, S., & García, L. E. (2016). The EMDR integrative group treatment protocol for patients with cancer. Journal of EMDR Practice and Research, 10(3), 199-207.
- BACKGROUNDJarero, I., Givaudan, M., & Osorio, A. (2018). Randomized controlled trial on the provision of the EMDR integrative group treatment protocol adapted for ongoing traumatic stress to female patients with cancer-related posttraumatic stress disorder symptoms. Journal of EMDR Practice and Research, 12(3), 94-104.